PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 185 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,049,000 | -15.1% | 169,553 | -4.6% | 0.05% | -19.4% |
| Q3 2019 | $4,768,000 | +40.0% | 177,769 | +41.6% | 0.07% | +28.8% |
| Q2 2019 | $3,405,000 | -22.6% | 125,521 | -1.0% | 0.05% | -26.8% |
| Q1 2019 | $4,400,000 | +63.9% | 126,801 | -7.8% | 0.07% | +34.0% |
| Q4 2018 | $2,685,000 | -34.5% | 137,540 | -10.6% | 0.05% | -19.7% |
| Q3 2018 | $4,097,000 | -30.2% | 153,836 | -1.0% | 0.07% | -31.2% |
| Q2 2018 | $5,866,000 | +60.9% | 155,317 | +39.2% | 0.10% | +54.8% |
| Q1 2018 | $3,645,000 | -18.1% | 111,608 | +22.1% | 0.06% | -18.4% |
| Q4 2017 | $4,449,000 | – | 91,402 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |